YayaNews LogoYaya Financial News
SECTION

#Oncology

Total 2 related articles

Live wire →

NewsTag

Featured

Celcuity Targets Q3 2026 for REVTORPYK Launch and sNDA Submission, Accelerating Commercialization
Lead report
美股

Lead report

Celcuity Targets Q3 2026 for REVTORPYK Launch and sNDA Submission, Accelerating Commercialization

Celcuity plans to ship REVTORPYK and file its sNDA by Q3 2026, backed by positive clinical data and commercial readiness. The market watches its execution as it transitions from clinical to commercial stage.

YayaNews2026-08-14 12:033 min
来源: Seeking Alpha
美股

Nuvation Bio Issues $200M Convertible Senior Notes: Financing Details and Market Impact Analysis

Nuvation Bio announces a $200M private placement of convertible senior notes to advance oncology drug development. This article analyzes the financing terms, company fundamentals, and market reaction, exploring potential impacts on stock price and pipeline.

YayaNews2026-06-25 19:133 min来源: Seeking Alpha
Nuvation Bio Issues $200M Convertible Senior Notes: Financing Details and Market Impact Analysis

More Related Articles